© 2005-2012 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.
This year, an estimated 69,740 people (37,600 men and 32,140 women) in the United States will be diagnosed with NHL. It is estimated that 19,020 deaths (10,590men and 8,430 women) from this disease will occur this year.
While some subtypes of NHL are common in children, NHL is more common in adults overall. NHL is the sixth most common cancer in women and the seventh most common cancer in men. It is also the seventh most common cause of cancer death among women and the ninth most common cause of cancer death in men.
The one-year relative survival rate (the percentage of people who survive at least one year after the cancer is detected, excluding those who die from other diseases) of patients with NHL is 81%. The five-year and 10-year relative survival rates are 68% and 57%, respectively, but vary depending on the subtype.
Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of people with different types and subtypes of lymphoma in the United States and may not apply to a single person or type of lymphoma. It is not possible to tell a person how long he or she will live with NHL. Because the survival statistics are often measured in multi-year intervals, they may not represent advances made in the treatment or diagnosis of this cancer. Learn more about understanding statistics.
Statistics adapted from the American Cancer Society’s publication, Cancer Facts & Figures 2013.